Nishadil
Nishadil Ads Nishadil Astrology Nishadil Developers Nishadil Domains Nishadil Drive Nishadil Finance Nishadil Pay Nishadil Weather Nishdil Calendar Rewards
Signup Signin
Washington | 27°C (clear sky)
Topic Feed

RevenueMiss

Showing the latest stories and updates for this topic.
Actinium Pharmaceuticals Faces Scrutiny After Challenging Q1 Financial Results

Actinium Pharmaceuticals Faces Scrutiny After Challenging Q1 Financial Results
HCL Tech's Shocking Plunge: What Sent the Stock Crashing Over 8%?

HCL Tech's Shocking Plunge: What Sent the Stock Crashing Over 8%?
Comtech's Q2 Takes a Hit: Satellite Woes Drag Down Earnings

Comtech's Q2 Takes a Hit: Satellite Woes Drag Down Earnings
Tompkins Financial Navigates Q4: A Look Beyond the Headline Numbers for Investors

Tompkins Financial Navigates Q4: A Look Beyond the Headline Numbers for Investors
A Challenging Quarter: Candel Therapeutics Navigates the Rocky Shores of Biotech Earnings

A Challenging Quarter: Candel Therapeutics Navigates the Rocky Shores of Biotech Earnings
Rockwell Medical's Latest Quarter: A Closer Look Beyond the Numbers

Rockwell Medical's Latest Quarter: A Closer Look Beyond the Numbers
The Shifting Sands of Tesla: When Vision Meets Reality in a Tough Market

The Shifting Sands of Tesla: When Vision Meets Reality in a Tough Market
The Q3 Report Card: LSI Industries Battles Headwinds, Analysts Eye the Path Ahead

The Q3 Report Card: LSI Industries Battles Headwinds, Analysts Eye the Path Ahead
Ispire Technology's Latest Unveiling: When the Numbers Don't Quite Align

Ispire Technology's Latest Unveiling: When the Numbers Don't Quite Align
The FiscalNote Forecast: A Quarter of Missed Marks and Market Musings

The FiscalNote Forecast: A Quarter of Missed Marks and Market Musings
The Green Haze Lingers: Cronos Group's Q3 Report Reveals a Winding Path Ahead

The Green Haze Lingers: Cronos Group's Q3 Report Reveals a Winding Path Ahead
The Green Energy Juggernaut Stumbles: Ameresco's Q3 Earnings Spark a Market Reckoning

The Green Energy Juggernaut Stumbles: Ameresco's Q3 Earnings Spark a Market Reckoning
Baxter's Unsettling Quarter: A Deep Dive into Disappointment and a Dimmed Horizon

Baxter's Unsettling Quarter: A Deep Dive into Disappointment and a Dimmed Horizon
The Golden Riddle: New Gold's Q3 Figures and the Market's Uneasy Dance

The Golden Riddle: New Gold's Q3 Figures and the Market's Uneasy Dance
Abbott Labs Faces Mixed Fortunes in Q3: Revenue Missed, But Earnings & Future Outlook Impress

Abbott Labs Faces Mixed Fortunes in Q3: Revenue Missed, But Earnings & Future Outlook Impress
Cosciens Biopharma's Q1 Unveils Growth Amidst Wider Losses

Cosciens Biopharma's Q1 Unveils Growth Amidst Wider Losses
Load more..